SecBot SecBot
144 ·Filed Sep 15, 2026

INBX

Inhibrx Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001959173-26-006980
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-dollar Form 144 filing by a director. The proposed sale of 500 shares ($52,525) is immaterial relative to the company's $1.6B market cap. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action is warranted based on this notice alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
INBX ▼ -16.22% at T+20d
NEUTRAL call -16.22% · α vs SPY -18.29% · entry $101.77 → $85.26
Next anchor: T+60d in 6w
Latest observation: T+27 -12.60% FF3 residual α
Entry = T+0 close
Sep 15, 2026
via day close
T+1d
+2.91%
call +2.91% · α +1.77%
$104.73
settled 6w ago
T+5d
-1.42%
call -1.42% · α -3.24%
$100.33
settled 5w ago
T+20d
-16.22%
call -16.22% · α -18.29%
$85.26
settled 14d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

No summary provided

Key Facts

  • Director Kimberly Manhard filed a Form 144 to sell 500 shares of INBX common stock.
  • The estimated aggregate market value of the proposed sale is $52,525.
  • The shares were acquired via open market purchase on August 28, 2024.
  • The Kimberly Joan Manhard Revoc Trust has sold 2,000 shares in four separate transactions from September 8-14, 2026, at prices between $55,130 and $57,897.50.
  • The filing is an advance notice of intent to sell; the sale may not be completed.

Financial Impact

Proposed sale of 500 shares valued at approximately $52,525, representing a negligible fraction of the $1.6B market cap.

dilution

Risk Factors

  • Insider selling could be perceived negatively by the market, though the small size of this filing makes that unlikely.
  • The filing is an intent to sell; the actual sale may not occur, but the notice itself signals the insider considered selling.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
80% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-006980
Document: 0001959173-26-006980-index.html0001959173-26-006980
Document: 0001959173-26-006980.txt0001959173-26-006980
18 reports for INBX
Performance horizon
50% Hit rate @ T+60 2 of 4 directional calls Went positive at some point 6 of 12 best @ T+60▲ +29.54%Jun 11, 2026
Filters
Rows
Reports for INBX — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
Insider Buy
BULLISH ★ 4/10
$90.50awaiting T+60—$91.07 (+0.63%)
Sep 28, 2026
28d ago
Insider Cluster
BULLISH ★ 5/10
$104.83awaiting T+60—$91.07 (−13.13%)
Sep 17, 2026
5w ago
Insider Cluster
BULLISH ★ 5/10
$109.35awaiting T+60—$91.07 (−16.72%)
Sep 15, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$101.77awaiting T+60—$91.07 (−10.52%)
Sep 15, 2026
5w ago
144
NEUTRAL ★ 2/10
$101.77awaiting T+60—$91.07 (−10.52%)
Sep 14, 2026
6w ago
144
NEUTRAL ★ 2/10
$105.61awaiting T+60—$91.07 (−13.77%)
Sep 11, 2026
6w ago
144
NEUTRAL ★ 2/10
$109.27awaiting T+60—$91.07 (−16.66%)
Sep 10, 2026
6w ago
Insider Cluster
BULLISH ★ 7/10
$109.27awaiting T+60—$91.07 (−16.66%)
Sep 8, 2026
6w ago
Insider Cluster
BULLISH ★ 6/10
$112.86awaiting T+60—$91.07 (−19.31%)
Sep 8, 2026
6w ago
Insider Buy
BULLISH ★ 6/10
$112.86awaiting T+60—$91.07 (−19.31%)
Showing 10 of 18

US Market Status

Market Open — Closes in 5h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026